New FDA rules aim to crack down on false and misleading claims by businesses trying to sell unproven, unregulated stem cell therapies.
Investigative Reporter Katie LaGrone explains.
New FDA rules aim to crack down on false and misleading claims by businesses trying to sell unproven, unregulated stem cell therapies.
Investigative Reporter Katie LaGrone explains.